PeptiDream Inc. (TYO:4587)
1,704.00
+24.00 (1.43%)
Dec 18, 2025, 11:30 AM JST
PeptiDream Revenue
PeptiDream had revenue of 4.31B JPY in the quarter ending September 30, 2025, a decrease of -21.15%. This brings the company's revenue in the last twelve months to 17.93B, down -62.47% year-over-year. In the year 2024, PeptiDream had annual revenue of 46.68B with 62.57% growth.
Revenue (ttm)
17.93B
Revenue Growth
-62.47%
P/S Ratio
12.11
Revenue / Employee
23.72M
Employees
621
Market Cap
217.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.68B | 17.96B | 62.57% |
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |
PeptiDream News
- 14 hours ago - PeptiDream Announces Promising Pre-Clinical Results of Proprietary Oral IL-17A and IL-17F Dual Inhibitor with Biologic-Like Efficacy for the Treatment of Psoriasis - Business Wire
- 12 days ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline Transcript - Seeking Alpha
- 12 days ago - PeptiDream Inc. (PPTDF) Discusses Progress in Radiopharmaceuticals and Peptide Therapeutics Pipeline - Slideshow - Seeking Alpha
- 1 year ago - PeptiDream: Opulent Dream Now A Reality - Seeking Alpha